# POMALIDOMIDE
> **ANDA209956** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2022-05-04
## Drug
- **FDA Application Number:** ANDA209956
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POMALIDOMIDE
- **Generic name:** POMALIDOMIDE
- **Active ingredients:** POMALIDOMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS USA
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2022-05-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209956)
---
*AI Analytics · CC0 1.0*